FDA approves female sexual desire drug made by Raleigh's Sprout Pharma

On Tuesday, the U.S. Food and Drug Administration approved flibanserin to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.